Curtiss-Wright (CW) Stock Outlook 2026: Where Nuclear Submarines Meet Small Modular Reactors

Curtiss-Wright. The name sounds like aviation history — and it is, tracing back to Glenn Curtiss and the Wright brothers. But today’s CW is a completely different animal: a defense and nuclear technology compounder that generates consistent double-digit earnings growth while the rest of the aerospace sector deals with Boeing’s production problems and Airbus supply chain drama. The stock is up approximately 89% year-over-year as of May 2026, yet most retail investors have never heard of it.

The reason for that obscurity is also the reason for its performance: Curtiss-Wright operates in programs that are strategically critical, technically complex, and completely uninteresting to general media coverage. Nuclear submarine propulsion control systems don’t make headlines. They also don’t get cancelled.

The Segment That Most Analysts Underweight

Ask investors why they own defense stocks and they’ll cite F-35 jets, missile programs, or cyber. Very few mention nuclear submarine propulsion control systems. That’s where CW sits.

The Naval & Power segment supplies critical electronic control and power management systems for nuclear-powered warships. The Columbia-class ballistic missile submarine (SSBN) program — America’s sea-based nuclear deterrent — is a long-duration program that crosses presidential administrations, party lines, and budget cycles without meaningful political challenge. These submarines carry Trident II D5 ballistic missiles and are considered the most survivable leg of the nuclear triad.

For investors, this translates to unusually high revenue visibility in a sector that normally suffers from program starts, stops, and political gyrations. A defense prime working on a conventional weapons platform might face program restructuring, quantity reductions, or outright cancellation. CW’s naval nuclear work faces almost none of that political variability.

Three Segments, All Growing in Q1 2026

Segment	Key Products	2026 Momentum
Defense Electronics	Power mgmt, flight data systems, traction inverters, sensors	All-segment growth confirmed Q1 2026
Naval & Power	Nuclear propulsion controls, power conversion, propulsion shafting	Columbia-class and commercial nuclear SMR exposure
Aerospace & Industrial	Sensors, electro-mechanical actuators, test equipment	Commercial aerospace recovery tailwind

The Q1 2026 results — 13% revenue growth, 23% EPS expansion — were notable because all three segments contributed simultaneously. This isn’t a single-program story riding one government contract. The breadth of growth demonstrates that CW’s diversified platform creates genuine multi-segment compounding. Management responded by raising full-year guidance for revenue, margins, and cash flow simultaneously — a signal of confidence that the Q1 performance was not an anomaly.

2026 Financial Snapshot

Metric	Value	Note
Stock Price	$742.59	May 27, 2026
Market Cap	$27.43B	+89.2% YoY
TTM Revenue	$3.61B	+12.2% YoY
FY2025 Revenue	$3.50B	+12.1% YoY
FY2024 Revenue	$3.12B	Prior year comparison
FY2025 Net Income	$511M	+18.9% YoY
FY2025 EPS	$13.65	+21.4% YoY
P/E	54.39x
Forward P/E	47.52x
Quarterly Dividend	$0.26/share	+8% raise in 2026
Revolving Credit	$1B	Expanded in 2026
Analyst Avg. Target	$788	Baird $870, Citi $775

Revenue grew over 12% in each of the past two fiscal years. EPS growth at 21% in FY2025 reflects operating leverage on that revenue growth — the combination of volume increase and margin expansion that defines a genuine compounder rather than just revenue growth.

The Submarine Supply Chain: Columbia-Class and Virginia-Class Together

Most investors who know CW at all know one program name: Columbia-class. That’s accurate but incomplete. The Naval & Power segment also serves Virginia-class (SSN-774) fast attack submarines, which run on a parallel production track at Huntington Ingalls Industries.

The Navy’s nuclear submarine production strategy is dual-stream by design. Columbia-class (SSBN) are the strategic deterrent boats — 12 planned, with the lead boat under construction. Virginia-class (SSN) are the fast attack force — a continuous production program that has been running for over two decades with multi-boat block contracts. Both programs use nuclear propulsion. Both require the kind of nuclear-qualified control electronics that CW specializes in.

This dual-program exposure is more important than most people realize. If Columbia-class faces schedule pressure from Huntington Ingalls’ notoriously tight shipyard capacity, Virginia-class revenue provides a cushion. CW isn’t a single-program bet on one shipbuilding slot; it’s a nuclear submarine supplier broadly defined.

The economics of that position are favorable: nuclear submarine programs are funded through multi-year authorization acts, are protected by strategic deterrence arguments, and generate long delivery lead times that translate into multi-year order backlogs. Revenue from a given submarine contract flows through CW’s P&L for years, smoothing the quarterly variation that makes other defense subcontractors harder to forecast.

The SMR Option Value: A Decade Away, But Already Positioning

Here is the less-discussed but potentially significant long-term angle: CW actively transitioned helium circulator systems for X-energy’s Xe-100 small modular reactor from design to prototype manufacturing in 2026. This is a concrete operational milestone, not a press release promise.

The Xe-100 is a high-temperature gas-cooled reactor (HTGR) designed for industrial heat and power applications. It has become increasingly relevant given data center electricity demand growth and industrial decarbonization pressures. CW’s role — designing and manufacturing the helium circulator, a critical moving component that circulates the coolant gas through the reactor — draws directly on its naval nuclear propulsion engineering heritage.

The engineering heritage matters here in a way that isn’t obvious. Nuclear-qualified systems must operate reliably in high-radiation environments for years without maintenance access. The materials science, quality control processes, and regulatory documentation required for naval nuclear propulsion are essentially the same skills required for commercial SMR component qualification. CW isn’t starting from scratch — it’s applying existing expertise to a new market.

SMR commercial deployment timelines remain uncertain. The Xe-100, like all commercial SMR designs, still faces a multi-year regulatory approval process before any units operate commercially. CW is appropriately cautious about projecting material near-term SMR revenue. But the strategic positioning is deliberate and forward-looking. When commercial SMRs achieve regulatory clearance — and U.S., U.K., and Canadian government policy is actively incentivizing this — CW will already have components qualified and prototypes tested.

This is option value in the classical sense: CW is paying a modest current cost (engineering time on prototype work) to preserve the right to participate in a potentially large future market. If SMRs deploy at scale, CW has a significant head start. If SMR timelines slip further, CW loses relatively little — its naval nuclear base remains intact.

The AP1000 Nuclear Restart Thesis: A Separate Thread

Beyond SMRs, there’s a related but distinct nuclear opportunity worth tracking: the AP1000 pressurized water reactor. Westinghouse’s AP1000 design has operating units in China and completed units at Plant Vogtle in the U.S. (completed 2024). As nuclear power benefits from renewed political and policy support — driven by decarbonization goals, data center electricity demand, and grid reliability concerns — incremental U.S. nuclear capacity additions become more plausible.

CW’s Naval & Power segment has industrial nuclear instrumentation and control expertise that extends beyond propulsion into commercial plant I&C systems. This isn’t a dominant revenue driver today, but it sits in the same engineering capabilities that serve naval nuclear. As the commercial nuclear pipeline expands — whether through AP1000 new builds, life extensions of existing plants, or eventual SMR deployments — CW’s relevant expertise expands with it.

The conventional view of CW as “submarine propulsion supplier” understates this broader nuclear positioning. The company has a claim on every part of the nuclear technology growth thesis: submarines, SMRs, and commercial plant systems.

European Rearmament: The Underappreciated Tailwind

One aspect of CW’s Defense Electronics segment that hasn’t received enough attention is the European rearmament tailwind. NATO member countries have substantially accelerated defense spending commitments following Russia’s invasion of Ukraine in 2022. This spending is flowing into ground vehicle electronics, naval systems, and airborne platform upgrades — all areas where CW’s Defense Electronics products are applicable.

CW’s power management electronics, sensors, and control systems appear in armored vehicles, naval vessels, and aircraft across multiple NATO programs. As European defense budgets increase and existing platforms receive mid-life electronics upgrades, CW’s addressable market in its Defense Electronics segment expands. This isn’t hypothetical — the Q1 2026 Defense Electronics growth reflects this dynamic already at work.

The ground vehicle angle deserves specific mention. CW makes traction inverters for electrified military vehicles — a product line with a long runway as NATO armies move toward hybrid and electric ground vehicle platforms. The transition away from purely diesel-powered armored vehicles is a gradual, multi-decade process, but CW is positioned for that transition technically and commercially. The defense electronics content per vehicle increases as powertrains become more complex.

The Dividend Growth Story: Why Consistent 8% Annual Increases Matter

An 8% dividend raise in 2026, continuing a 10-year streak, is a message from management that deserves unpacking.

The math on compounding: an investor who purchased CW shares at the time of the first dividend increase in this streak and has held through today has seen the quarterly dividend increase substantially while the share count remained stable. For long-term compounding-oriented investors, this is the actual return driver alongside price appreciation.

More importantly, the sustained dividend growth reflects management’s confidence in FCF generation. Defense contract businesses that generate predictable cash flow from long-cycle programs can sustain dividend growth policies precisely because their revenue doesn’t swing dramatically quarter to quarter. CW’s ability to maintain and grow this dividend through defense budget debates, COVID disruptions, and macro uncertainty speaks to the underlying FCF stability.

The absolute yield (~0.14% at current prices) is not the point for growth investors. The point is that management is committing to growing cash returns to shareholders year after year — a commitment that requires confidence in the multi-year earnings trajectory.

Ten consecutive years of increases puts CW on a path toward the S&P 500 Dividend Aristocrats threshold (25 years required), which is still a decade-plus away. But the commitment to the streak itself is informative. Companies that raise dividends 10 years in a row have demonstrated a specific kind of capital discipline: they won’t make a dividend promise they can’t keep. That discipline is a signal about FCF quality and management credibility that transcends the actual dollar amount.

Segment-Level Valuation Framework

The “54x P/E on the total company” framing understates the valuation complexity. Different segments deserve different multiples, and building a segment-level view provides a cleaner analytical foundation.

Naval & Power carries the highest quality multiple — defense electronics serving strategic programs with multi-year government contract visibility. A reasonable comps-based multiple for this segment quality: 55–65x earnings, reflecting the program duration and political protection. This is the engine that justifies CW’s overall premium.

Defense Electronics is higher-growth but more exposed to export controls, competitive dynamics in tactical electronics, and program concentration risk. A fair multiple for this segment quality: 45–55x, acknowledging the faster growth offset by less certainty versus naval nuclear.

Aerospace & Industrial is the more cyclical segment with commercial aerospace exposure. The recovery from COVID-era demand weakness creates a multi-year tailwind, but the ceiling here is more conventional — closer to industrial compounder multiples of 30–40x.

The blended result at current segment mix: a fair aggregate P/E of 45–55x for a growing defense compounder with nuclear exposure. The current 54x Forward P/E falls within that range, suggesting the valuation is fully priced for the current growth rate but not egregiously stretched if execution continues.

The key insight: CW’s multiple is not pure growth euphoria. It’s a defensible multiple for the quality of revenue visibility the company actually has.

Three Scenarios for 2026–2028

Base Case — Defense Growth Continues

Columbia-class program remains on schedule. Defense Electronics wins incremental European rearmament orders. Aerospace & Industrial benefits from commercial aviation recovery. FY2026 EPS reaches $15–16 range, stock tracks to analyst consensus range of $750–800. Continued 8%+ annual dividend increases. This is the expected path if execution matches the Q1 2026 momentum.

Bull Case — SMR Catalyst Materializes and European Demand Accelerates

U.S. government accelerates SMR deployment incentives through the permitting and financing mechanisms. X-energy Xe-100 advances meaningfully toward construction authorization. CW’s SMR backlog becomes visible to analysts. Simultaneously, European defense spending drives Defense Electronics above current growth rates. Multiple expands as analysts add SMR optionality to valuation models. Stock approaches Baird’s $870 target. From $742.59, the upside to $870 is approximately 17%.

Bear Case — Columbia-class Delay and Earnings Miss

Huntington Ingalls (the shipbuilder responsible for Columbia-class construction) faces additional production delays, cascading into delayed CW deliveries. Naval & Power revenue growth slows meaningfully. If combined with a Defense Electronics miss, EPS falls below expectations. The 54x P/E provides little cushion for earnings disappointment — a 10% earnings miss at a 54x multiple could drive a 20%+ stock decline. Stock retreats to the $600–650 range. This scenario is painful but doesn’t impair the underlying franchise — the Columbia-class program doesn’t go away, it slows.

Hypothetical Decision Tree: Three Investor Profiles

These scenarios are illustrative examples for framing investment decisions, not recommendations.

Hypothetical Investor A — Defense thematic holder, 5-year horizon

A hypothetical portfolio manager with existing HII and GD positions wants naval supply chain exposure without duplicating the prime contractor angle. CW provides the subcontractor complement: HII builds the ships, GD makes the Trident missiles, CW supplies the propulsion control electronics. A 3–5% position in CW alongside HII would give this portfolio the full Columbia-class supply chain without over-concentration in any single program. The 54x P/E is acceptable for a 5-year horizon if earnings compound at 15% annually — which CW has demonstrated it can do.

Hypothetical Investor B — Nuclear revival thesis, 10-year horizon

A hypothetical individual investor who is constructive on commercial nuclear power and wants equity exposure before SMR revenue materializes. Directly investing in early-stage SMR developers carries technology risk; buying a major nuclear utility carries low-growth utility risk. CW offers a middle path: a profitable, cash-flowing defense compounder where SMR is pure option value. If the SMR thesis plays out over 10 years, CW participates meaningfully without requiring it for the base case.

Hypothetical Investor C — Dividend growth seeker, income-oriented

A hypothetical retiree building a dividend growth portfolio wants defense exposure with a growing income stream. The 0.14% current yield is unattractive on a yield basis, but the 8% annual growth rate means the yield-on-cost doubles in roughly nine years. Starting from a 0.14% yield at $742, a nine-year holder would be earning roughly 0.28% yield on original cost — still not impressive in absolute terms, but supplemented by the stock appreciation that enabled the compounding. For dividend growth investors, CW is more attractive as a starter position at lower prices than today’s level.

Risk Register

Risk	Level	Note
Columbia-class schedule slip	Medium	Dependent on HII shipyard execution
SMR timeline uncertainty	Medium	Commercial deployment still years away
P/E multiple compression	Medium	Growth disappointment would hurt valuation
Defense budget political risk	Low	Strategic nuclear programs are politically protected
Customer concentration in Naval & Power	Low-Medium	Columbia and Virginia programs diversify somewhat
Revolving credit facility costs	Low	Expanded to $1B, currently well-managed
European defense spending pullback	Low	NATO spending commitments remain strong
M&A integration risk	Low	CW’s acquisition history has been disciplined

CW vs. HEI vs. TDG: Quality Compounder Comparison

This is worth structuring explicitly, because investors frequently face the question of which defense compounder deserves allocation.

Metric	CW	HEI	TDG
P/E (approx.)	54x	55x	39x
Gross Margin	~22%	~40%	~57%
Leverage	Low	Low	Very High
Dividend Policy	Growing regular	Token regular	Irregular special
Moat Type	Program visibility, nuclear heritage	FAA-PMA catalog, family control	Proprietary parts captive aftermarket
SMR/Nuclear Optionality	Yes	No	No
Revenue Predictability	Very High	High	High

The key insight from this comparison: CW is the only one of the three with explicit nuclear technology optionality. HEI and TDG are aerospace aftermarket compounders; CW is a defense compounder with a nuclear energy kicker. For investors who are constructive on nuclear power’s long-term role in electricity generation, CW carries an asymmetric upside that neither HEI nor TDG provides.

The leverage contrast matters too. TDG’s $1.58B annual interest expense means the business must generate reliable aftermarket FCF every year to stay current. CW’s balance sheet carries no such pressure — the $1B revolving credit facility is a strategic tool, not a structural dependency. In a stress scenario, CW has far more financial flexibility than TDG.

How to Monitor the CW Investment Thesis

Primary sources to track:

1. CW quarterly earnings — specifically segment revenue breakdown for Naval & Power versus Defense Electronics. Any decline in Naval & Power as a percentage of total revenue warrants examination.

2. DoD Daily Contract Awards (defense.gov/News/Contracts) — the Department of Defense publishes all contract awards daily. Filtering for “Curtiss-Wright” will show new contract wins and extensions, providing real-time signal on the order book.

3. Huntington Ingalls Industries (HII) quarterly earnings — HII’s Columbia-class commentary directly affects CW’s Naval & Power delivery schedule. HII management typically discusses Columbia-class production milestones; positive updates are positive for CW.

4. NRC (Nuclear Regulatory Commission) docket activity — X-energy’s Xe-100 Combined License Application (COLA) process will appear in NRC public dockets. Milestones in that process indicate progress toward commercial SMR deployment and, by extension, when CW’s SMR component work might translate into revenue.

5. CW dividend announcements — continuation of the 8%+ annual dividend growth streak is a real-time signal of management confidence in FCF trajectory.

Portfolio Context: How CW Fits with Other Defense Holdings

CW sits in an interesting position in a defense portfolio. It offers lower leverage than TransDigm (TDG), higher program visibility than general defense electronics, and a nuclear energy option that no other defense company provides in quite the same way.

Investors holding Huntington Ingalls Industries (HII) as a Columbia-class beneficiary should consider CW as a complementary position — HII builds the submarines, CW supplies the control systems. The two are not competitors; they’re supply chain partners serving the same end program.

For investors comparing CW to Mercury Systems (MRCY), the key distinction is program stability. CW’s naval nuclear contracts are among the most durable in U.S. defense. MRCY’s defense electronics business is growing fast but still recovering from a difficult FY2024. CW is the lower-risk, lower-upside option; MRCY is the higher-risk, higher-upside turnaround story.

The CW/HEI comparison is the closest in character: both are premium-multiple compounders in the defense and aerospace space with disciplined management teams and durable competitive positions. The differentiator is domain: HEI’s moat is regulatory compliance at scale (FAA-PMA catalog); CW’s moat is nuclear-qualification heritage. Investors who believe nuclear energy is entering a multi-decade expansion have a clear reason to prefer CW’s optionality. Investors who want the most defensible recurring revenue in the broadest aerospace market may prefer HEI’s PMA catalog breadth.

Related Reading

• TransDigm (TDG) Stock Outlook 2026: The Aftermarket Pricing Machine
• Mercury Systems (MRCY) Outlook 2026: Defense Embedded Computing Turnaround
• Hexcel (HXL) Stock Outlook 2026: Carbon Fiber Composites Cycle
• EHang (EH) Stock Outlook 2026: China’s First Passenger eVTOL Type Certificate
• Northrop Grumman (NOC): B-21 Raider and Space Defense
• General Dynamics (GD): Submarines and Defense Diversification
• L3Harris Technologies: Electronic Warfare and Satellite Communications

---

The CW investment case is built on a foundation that rarely shifts: the U.S. maintains nuclear deterrence through submarine-launched ballistic missiles, those submarines need propulsion, and CW supplies critical systems for that propulsion. Layered on top is an SMR optionality story with a 5–10 year payoff horizon, an AP1000 commercial nuclear thread, and a European rearmament tailwind that’s already visible in earnings. None of those pieces is glamorous. All of them are durable. That’s usually a good combination for patient capital willing to pay a premium multiple — and the key question is whether you’re buying the earnings compounding or the optionality. At 54x, you’re paying for both.